Oral Breast Cancer Therapy Interventions in an Integrated Health System Specialty Pharmacy
We are proud to support the groundbreaking work of our specialty pharmacy solution, Lumicera Health Services. In alignment with our commitment to improving patient outcomes, a dedicated team of Lumicera pharmacists have authored a new white paper exploring the impact of pharmacist-led interventions in oral breast cancer therapy.
This multiyear study provides compelling statistical and clinical evidence of how pharmacist engagement influences the patient journey, from intervention acceptance rates to measurable improvements in outcomes. It’s a powerful example of how data-driven care and compassionate expertise can elevate the standard of specialty pharmacy.
We invite you to read the white paper and learn more about how Lumicera is driving innovation in oncological care.
Stay Informed and Connected
Receive expert insights, healthcare tips, and important updates on pharmacy benefits, drug recalls, and more—straight to your inbox.
CLARITY FOR ACTION
Gain Clarity: Navitus 10th Annual Drug Trend Report Ready to Download
Our 2025 report provides transparent, data-driven insight to help plans, plan sponsors and consultants navigate an increasingly complex prescription drug landscape.
Related blogs
Navigating Healthcare and Improving Outcomes
Get to Know the PBM Pass-through Model
In the world of pharmacy benefit management (PBM), there are multiple models a company can follow, including the pass-through, hybrid and traditional models. While all PBMs negotiate discounts and rebates with manufacturers on behalf of their clients,…
